Project Summary for Specimen CMET Second Release
Visit Project Insight to see the full project details. *
Project Details
Number | 682 View Ballot Items List (with NIBs) |
---|---|
Name | Specimen CMET Second Release |
Sponsor(s) | Orders and Observations Work Group |
Co-Sponsor(s) | Clinical Genomics Work Group, Imaging Integration Work Group |
Steering Division | Administrative |
Description | Specimen CMET Develop and ballot the second release of the specimen related CMETs and reviewing existing V2 artefacts to support Clinical Genomics and/or Image Integration requirements. The major tasks that have been identified are: - Apply work outcomes of the Specimen DAM analysis to the v3 CMET models as well evaluating requirements for version 2 changes. - Complete Specimen v3 models based on these use cases and change requests recorded against the existing models - Support Specimen Identifier formats as further established by AP workgroup V2.x - Modeling efforts will be reviewed for potential v2 updates, which will be fed into the existing version 2 change management process where appropriate. |
Project Facilitator | Riki Merrick, Lorraine Constable |
Status | Archived |
SD Approval Date | May 14, 2012 |
TSC Approval Date | Jun 11, 2012 |
Type | Ballot - STU to Normative |
Objectives / Deliverables | V3 CMET/ RMIM compare and updates DSTU - Target: September 2016 V2 SPM compare and update change requests for V2.x - Target: V2.x dependent Normative Ballot (target, will create separate pss) - Target: September 2014 |
Next Milestone Date | 2019 January WGM |
Project End Date | 2020 January WGM |
Project Intent | Create New Standard, Revise Current Standard |
Project Need | The first release of the Specimen CMETs focused on requirements for general laboratory testing of specimens. The second release of Specimen CMETs will include requirements from the clinical genomics domain as well as other domains such as imaging. The second release can also include changes to the existing specimen CMETs to correct problems as identified in change requests submitted to the Orders and Observations work group. |
Implementers | 1) The Association of Public Health Laboratories (APHL) 2) Canadian Biosample Repository, University of Alberta |
Security Risks | |
External Drivers | |
Common Names / Keywords/ Aliases | |
Lineage | |
Dependancies | CG Project 705 - CG-omics Domain Analysis Model Specimen CMET dependent on OO Specimen DAM development Related work: AP Project 862 - Unique Specimen Identifier Requirements - Informative Work Project 773 - version 2.9 Messaging for v2 Related updates |
Project Document Repository |
Project Wiki page: http://wiki.hl7.org/index.php?title=Specimen HL7 GForge/SVN - V3 artifact repository |
Backwards Compatibility | Yes |
External Vocabularies | |
Products | |
Joint Copyright? | |
External Pjt Collaborators | None |
Realm | Universal |
HL7 Affiliate | |
Stakeholders | Clinical and Public Health Laboratories, Standards Development Organizations (SDOs) |
Vendors | EHR, PHR; Lab; HIS |
Providers | Clinical and Public Health Laboratories; Medical Imaging Service; Healthcare Institutions (hospitals, long term care, home care, mental health) |
Ballot Cycle Info | Leave blank until NIB is submitted |
Misc Notes | 2020 Sept: LConstable: This has been on hold for a while. We moved to archive it, as we are not planning to do new v3 CMET work. WGM Jan2015: Specimen DAM was published by May2015. Working on second release before applying to V3 CMET and V2. |
U.S. Govt Interest? | Yes |
USRSC Approval | |
FMG Approval | |
ARB Approval | |
Start Date | Jun 14, 2016 |
* A Project Insight User ID and password is required to access Project Insight. Contact the HL7 PMO at for more information.
Visit the Projects, Ballots and Standards Metrics Excel Report to view projects that are behind 120+ days along with other ballots and standards requiring a Work Group's attention.
Visit the Projects, Ballots and Standards Metrics Excel Report to view projects that are behind 120+ days along with other ballots and standards requiring a Work Group's attention.